New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
09:03 EDTATRS, DCTHAntares Pharma announces resignation of CEO Wotton, names Hobbs as CEO
Antares Pharma (ATRS) announced the resignation of Paul K. Wotton, Ph.D. who informed the companys Board of Directors that he will assume the position of CEO of a development stage biotechnology company. Wotton also has resigned from the Antares Board of Directors. Antares Pharma also announced today the appointment of Eamonn P. Hobbs to the position of President and CEO of the company effective immediately. Hobbs joined the Antares Board of Directors in August 2009 and has over 30 years of experience in the pharmaceutical, medical device, and combination products industry, including the medical specialty fields of radiology, vascular surgery, interventional cardiology, oncology and gastroenterology. Hobbs was previously the President and CEO of Delcath Systems (DCTH).
News For ATRS;DCTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
07:23 EDTDCTHEuropean Society of Surgical Oncology to hold a conference
34th ESSO Conference is being held in Liverpool, England on October 29-31.
October 22, 2014
10:09 EDTATRSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:58 EDTATRSAntares Pharma initiated with an Outperform at JMP Securities
Target $4.
October 20, 2014
09:04 EDTATRSAdvanced Cell Technology names LeRoux Jooste as CCO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use